# Jung‐Hwan Yoon

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jung-hwan-yoon/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,609 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 72 |
| i10-index | 328 |
| Last Known Institution | Seoul National University |
| OpenAlex ID | https://openalex.org/A5035961207 |
| ORCID iD | https://orcid.org/0000-0002-9128-3610 |
| Works | 694 |

## Researcher papers

- [Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial](https://scholariq.org/papers/lenvatinib-versus-sorafenib-for-first-line-treatment-of-unresectable/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Researcher university

- [Seoul National University](https://scholariq.org/institutions/seoul-national-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.